Pimivalimab - Research Grade Biosimilar, CAS [[2293951-22-9]], Unconjugated, Monoclonal
Artikelnummer:
PRS-21-950
Artikelname: |
Pimivalimab - Research Grade Biosimilar, CAS [[2293951-22-9]], Unconjugated, Monoclonal |
Artikelnummer: |
PRS-21-950 |
Hersteller Artikelnummer: |
21-950 |
Alternativnummer: |
PRS-21-950-0.1 |
Hersteller: |
ProSci |
Kategorie: |
Antikörper |
Immunogen: |
Homo sapiens / PDCD1 |
Konjugation: |
Unconjugated |
Alternative Synonym: |
IMMUNOGLOBULIN G4 (226-PROLINE,C-TERMINAL-LYSINE-CLIPPED), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL JTX-4014 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JTX-4014 .KAPPA.-CHAIN, DIMER JTX 4014 [WHO-DD], JTX-4014, PIMIVALIMAB, PI |
Klonalität: |
Monoclonal |
Konzentration: |
batch dependent |
NCBI: |
5133 |
UniProt: |
Q15116 |
Puffer: |
PBS buffer pH 7.5 |
Quelle: |
CHO cells |
Reinheit: |
>95% |
CAS Nummer: |
[2293951-22-9] |
Application Verdünnung: |
For research use only . |